Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1.

Blood Adv · 2025 · PMC12661299 · PMID 40864183

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

CD19 + B-cell frequencies remained stable throughout early treatment cycles, with an increasing trend noted at cycle 7 ( Figure 4 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.